These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 318732)

  • 1. Association of graft survival with host response to hepatitis B infection in patients with kidney transplants.
    London WT; Drew JS; Blumberg BS; Grossman RA; Lyons PJ
    N Engl J Med; 1977 Feb; 296(5):241-4. PubMed ID: 318732
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatitis B virus infection in allogeneic bone marrow transplantation.
    Ustün C; Koç H; Karayalcin S; Akyol G; Gürman G; Ilhan O; Akan H; Ozcan M; Arslan O; Konuk N; Uysal A; Beksaç M
    Bone Marrow Transplant; 1997 Aug; 20(4):289-96. PubMed ID: 9285543
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of HBsAg-positivity of kidney donors on long-term patient and graft outcome.
    Berber I; Aydin C; Yigit B; Turkmen F; Titiz IM; Altaca G
    Transplant Proc; 2005 Dec; 37(10):4173-5. PubMed ID: 16387070
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Change in the serologic markers of hepatitis B after allogenic hematopoietic stem-cell transplantation].
    Woo SY; Cho SH; Lee SM; Koh MB; Noh CH; Kim CW; Choi JY; Yang JM; Han JY; Lee YS
    Korean J Hepatol; 2009 Jun; 15(2):131-9. PubMed ID: 19581765
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Humoral and cellular immune responses to hepatitis B vaccination in hepatitis B surface antigen-carrier children who cleared serum-hepatitis B surface antigen.
    Hsu HY; Chang MH; Hsieh RP; Ni YH; Chi WK
    Hepatology; 1996 Dec; 24(6):1355-60. PubMed ID: 8938161
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transplanting kidneys from donors with prior hepatitis B infection: one response to the organ shortage.
    Fabrizio F; Bunnapradist S; Martin P
    J Nephrol; 2002; 15(6):605-13. PubMed ID: 12495272
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-titer antibody to hepatitis B surface antigen before liver transplantation can prevent de novo hepatitis B infection.
    Su WJ; Ho MC; Ni YH; Chen HL; Hu RH; Wu YM; Chang MH; Lee PH
    J Pediatr Gastroenterol Nutr; 2009 Feb; 48(2):203-8. PubMed ID: 19179883
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Hepatitis B virus reactivation in patients with HBs antibodies after allogeneic hematopoietic stem cell transplantation].
    Fujimaki K; Nakaseko C; Oshima K; Sakai M; Chou R; Kanda Y; Nishimura M; Kanamori H; Sakamaki H
    Rinsho Ketsueki; 2007 May; 48(5):386-90. PubMed ID: 17571583
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ten-year follow-up of kidney transplantation from hepatitis B surface antigen-positive donors.
    Sumethkul V; Ingsathit A; Jirasiritham S
    Transplant Proc; 2009; 41(1):213-5. PubMed ID: 19249516
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of hepatitis B core antibody-positive donor kidneys in hepatitis B surface antibody-positive and -negative recipients.
    Veroux M; Puliatti C; Gagliano M; Cappello D; Macarone M; Vizcarra D; Spataro M; Di Mare M; Ginevra N; Veroux P
    Transplant Proc; 2005; 37(6):2574-5. PubMed ID: 16182748
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatitis B virus infection after renal transplantation in the presence of antibody to hepatitis B surface antigen immunity.
    Kim KH; Ahn SH; Chung HY; Paik YH; Lee KS; Kim YS; Chon CY; Moon YM; Han KH
    J Gastroenterol Hepatol; 2004 Aug; 19(8):847-53. PubMed ID: 15242485
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatitis B surface antigen (HBsAg) infection in a hemodialysis unit. II. Factors affecting host immune response to HBsAg.
    Sengar DP; Rashid A; McLeish WA; Harris JE; Couture RA; Sutherland M
    Can Med Assoc J; 1975 Nov; 113(10):945-8. PubMed ID: 1104126
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kidney transplantation from hepatitis B surface antigen-positive donors into hepatitis B surface antigen-positive recipients: preliminary findings.
    Veroux M; Puliatti C; Macarone M; Cappello D; Gagliano M; Spataro M; Di Mare M; Giuffrida G; Veroux P
    Transplant Proc; 2005; 37(6):2467-8. PubMed ID: 16182711
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HBsAg as predictor of outcome in renal transplant patients.
    Ridruejo E; Brunet Mdel R; Cusumano A; Diaz C; Michel MD; Jost L; Jost L; Mando OG; Vilches A
    Medicina (B Aires); 2004; 64(5):429-32. PubMed ID: 15560544
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunoregulation of the in vitro anti-HBs antibody synthesis in chronic HBsAg carriers and in recently boosted anti-hepatitis B vaccine recipients.
    Barnaba V; Valesini G; Levrero M; Zaccari C; Van Dyke A; Falco M; Musca A; Balsano F
    Clin Exp Immunol; 1985 May; 60(2):259-66. PubMed ID: 3874020
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The LifeLink Foundation and cadaver kidney transplantation in Tampa.
    LeFor WM; Wright CE; Bowers VD; Heinrichs DF; Shires DL
    Clin Transpl; 1999; ():149-58. PubMed ID: 11038633
    [TBL] [Abstract][Full Text] [Related]  

  • 17. De novo hepatitis B after liver transplantation from hepatitis B core antibody-positive donors in an area with high prevalence of anti-HBc positivity in the donor population.
    Prieto M; Gómez MD; Berenguer M; Córdoba J; Rayón JM; Pastor M; García-Herola A; Nicolás D; Carrasco D; Orbis JF; Mir J; Berenguer J
    Liver Transpl; 2001 Jan; 7(1):51-8. PubMed ID: 11150423
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preemptive lamivudine therapy based on HBV DNA level in HBsAg-positive kidney allograft recipients.
    Chan TM; Fang GX; Tang CS; Cheng IK; Lai KN; Ho SK
    Hepatology; 2002 Nov; 36(5):1246-52. PubMed ID: 12395336
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heart transplantation using donors positive for hepatitis.
    Wang SS; Chou NK; Ko WJ; Yu HY; Chen YS; Hsu RB; Huang SC; Chi NH; Tsao CI; Lai MY; Liau CS; Lee YT
    Transplant Proc; 2004 Oct; 36(8):2371-3. PubMed ID: 15561252
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of presence of HBs antigen and anti-hepatitis C virus and anti-cytomegalovirus antibodies on transplanted kidney survival.
    Sieńko J; Wiśniewska M; Ciechanowski K; Rózański J; Domański L; Myslak M; Kamiński M; Sulikowski T; Pabisiak K; Romanowski M; Mizerski A; Tejchman K; Nowacki M; Ostrowski M; Bohatyrewicz R
    Transplant Proc; 2006; 38(1):136-8. PubMed ID: 16504685
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.